JPY 2388.0
(0.55%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 14.2 Billion JPY | 14.07% |
2022 | 12.45 Billion JPY | 18.46% |
2021 | 10.51 Billion JPY | -2.0% |
2020 | 10.72 Billion JPY | 7.13% |
2019 | 10.01 Billion JPY | -2.74% |
2018 | 10.29 Billion JPY | 6.8% |
2017 | 9.63 Billion JPY | -0.99% |
2016 | 9.73 Billion JPY | 8.11% |
2015 | 9 Billion JPY | -3.06% |
2014 | 9.28 Billion JPY | 6.05% |
2013 | 8.75 Billion JPY | 6.18% |
2012 | 8.24 Billion JPY | 12.28% |
2011 | 7.34 Billion JPY | 13.65% |
2010 | 6.46 Billion JPY | -13.21% |
2009 | 7.44 Billion JPY | 19.4% |
2008 | 6.23 Billion JPY | 19.46% |
2007 | 5.22 Billion JPY | -6.8% |
2006 | 5.6 Billion JPY | -21.8% |
2005 | 7.16 Billion JPY | 3.6% |
2004 | 6.91 Billion JPY | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 14.06 Billion JPY | -0.99% |
2023 Q4 | 14.2 Billion JPY | 7.5% |
2023 Q3 | 13.21 Billion JPY | -1.03% |
2023 FY | 14.2 Billion JPY | 14.07% |
2023 Q2 | 13.34 Billion JPY | 1.07% |
2023 Q1 | 13.2 Billion JPY | 6.09% |
2022 Q1 | 10.79 Billion JPY | 2.69% |
2022 Q4 | 12.45 Billion JPY | 8.78% |
2022 FY | 12.45 Billion JPY | 18.46% |
2022 Q3 | 11.44 Billion JPY | 1.09% |
2022 Q2 | 11.32 Billion JPY | 4.9% |
2021 Q3 | 9.57 Billion JPY | -3.4% |
2021 Q1 | 10.21 Billion JPY | -4.73% |
2021 Q2 | 9.91 Billion JPY | -2.99% |
2021 Q4 | 10.51 Billion JPY | 9.77% |
2021 FY | 10.51 Billion JPY | -2.0% |
2020 Q1 | 10.43 Billion JPY | 4.26% |
2020 Q4 | 10.72 Billion JPY | 1.85% |
2020 FY | 10.72 Billion JPY | 7.13% |
2020 Q3 | 10.52 Billion JPY | 1.83% |
2020 Q2 | 10.34 Billion JPY | -0.92% |
2019 Q4 | 10.01 Billion JPY | 6.13% |
2019 FY | 10.01 Billion JPY | -2.74% |
2019 Q1 | 9.91 Billion JPY | -3.62% |
2019 Q3 | 9.43 Billion JPY | 0.38% |
2019 Q2 | 9.39 Billion JPY | -5.27% |
2018 FY | 10.29 Billion JPY | 6.8% |
2018 Q1 | 10.09 Billion JPY | 4.75% |
2018 Q2 | 10.19 Billion JPY | 1.0% |
2018 Q3 | 9.7 Billion JPY | -4.78% |
2018 Q4 | 10.29 Billion JPY | 6.0% |
2017 FY | 9.63 Billion JPY | -0.99% |
2017 Q4 | 9.63 Billion JPY | 4.08% |
2017 Q3 | 9.25 Billion JPY | -3.83% |
2017 Q2 | 9.62 Billion JPY | -2.39% |
2017 Q1 | 9.86 Billion JPY | 1.35% |
2016 Q3 | 8.92 Billion JPY | -3.23% |
2016 Q1 | 9.15 Billion JPY | 1.71% |
2016 Q2 | 9.22 Billion JPY | 0.71% |
2016 FY | 9.73 Billion JPY | 8.11% |
2016 Q4 | 9.73 Billion JPY | 9.07% |
2015 Q2 | 8.64 Billion JPY | -4.07% |
2015 Q3 | 8.59 Billion JPY | -0.59% |
2015 Q4 | 9 Billion JPY | 4.71% |
2015 Q1 | 9.01 Billion JPY | -2.92% |
2015 FY | 9 Billion JPY | -3.06% |
2014 Q2 | 8.91 Billion JPY | 1.03% |
2014 Q3 | 8.63 Billion JPY | -3.12% |
2014 FY | 9.28 Billion JPY | 6.05% |
2014 Q1 | 8.82 Billion JPY | 0.72% |
2014 Q4 | 9.28 Billion JPY | 7.58% |
2013 FY | 8.75 Billion JPY | 6.18% |
2013 Q4 | 8.75 Billion JPY | 9.82% |
2013 Q1 | 8.22 Billion JPY | -0.22% |
2013 Q2 | 8.43 Billion JPY | 2.53% |
2013 Q3 | 7.97 Billion JPY | -5.49% |
2012 Q3 | 7.5 Billion JPY | -0.11% |
2012 Q4 | 8.24 Billion JPY | 9.87% |
2012 Q2 | 7.51 Billion JPY | -0.63% |
2012 Q1 | 7.56 Billion JPY | 2.95% |
2012 FY | 8.24 Billion JPY | 12.28% |
2011 Q3 | 7.53 Billion JPY | -0.16% |
2011 FY | 7.34 Billion JPY | 13.65% |
2011 Q1 | 7.4 Billion JPY | 14.56% |
2011 Q2 | 7.54 Billion JPY | 1.93% |
2011 Q4 | 7.34 Billion JPY | -2.52% |
2010 Q3 | 6.72 Billion JPY | 9.36% |
2010 Q1 | 6.5 Billion JPY | -12.61% |
2010 FY | 6.46 Billion JPY | -13.21% |
2010 Q4 | 6.46 Billion JPY | -3.82% |
2010 Q2 | 6.14 Billion JPY | -5.58% |
2009 Q3 | 7.05 Billion JPY | 6.36% |
2009 Q4 | 7.44 Billion JPY | 5.56% |
2009 Q2 | 6.63 Billion JPY | 0.0% |
2009 FY | 7.44 Billion JPY | 19.4% |
2008 Q4 | 6.23 Billion JPY | 3.4% |
2008 FY | 6.23 Billion JPY | 19.46% |
2008 Q3 | 6.03 Billion JPY | 0.0% |
2007 FY | 5.22 Billion JPY | -6.8% |
2006 FY | 5.6 Billion JPY | -21.8% |
2005 FY | 7.16 Billion JPY | 3.6% |
2004 FY | 6.91 Billion JPY | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 6.71 Billion JPY | -111.434% |
Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 98.826% |
Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 87.688% |
Shionogi & Co., Ltd. | 64.91 Billion JPY | 78.122% |
Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -607.964% |
Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 63.688% |
Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | 17.272% |
Eisai Co., Ltd. | 174.65 Billion JPY | 91.868% |
Morishita Jintan Co., Ltd. | 3.18 Billion JPY | -345.903% |
Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 32.934% |
Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 53.095% |
Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | -32.457% |
Tsumura & Co. | 117.61 Billion JPY | 87.925% |
Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 45.992% |
Torii Pharmaceutical Co., Ltd. | 10.74 Billion JPY | -32.21% |
Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 85.949% |
Fuji Pharma Co., Ltd. | 19.37 Billion JPY | 26.684% |
Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | 1.986% |
KYORIN Holdings, Inc. | 53.47 Billion JPY | 73.439% |
Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -627.561% |
Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 32.015% |
SymBio Pharmaceuticals Limited | 232.03 Million JPY | -6020.76% |
MedRx Co., Ltd | 10 Million JPY | -141920.0% |
Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -789.511% |
Solasia Pharma K.K. | 122 Million JPY | -11540.984% |
Modalis Therapeutics Corporation | 6.35 Million JPY | -223447.93% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 30.389% |
Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 85.798% |
Cyfuse Biomedical K.K. | 46.04 Million JPY | -30743.74% |
Toho Holdings Co., Ltd. | 87.28 Billion JPY | 83.73% |
Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | -526.672% |